Hirofumi Misu Selected Research

Hirofumi Misu Research Topics

Disease

33	Insulin Resistance 01/2020 - 01/2007
18	Type 2 Diabetes Mellitus (MODY) 08/2019 - 03/2007
8	Non-alcoholic Fatty Liver Disease 03/2015 - 11/2007
7	Obesity 08/2019 - 11/2007
5	Inflammation (Inflammations) 02/2015 - 11/2007
5	Fibrosis (Cirrhosis) 05/2014 - 01/2007
4	Hyperglycemia 03/2019 - 03/2015
4	Fatty Liver 05/2009 - 01/2007
3	Body Weight (Weight, Body) 01/2020 - 01/2012
3	Glucose Intolerance 08/2019 - 11/2018
3	Alcoholic Fatty Liver 06/2015 - 07/2008
3	Neoplasm Metastasis (Metastasis) 01/2012 - 01/2008
2	Weight Cycling 01/2020 - 01/2016
2	Overweight 05/2019 - 05/2018
2	Starvation 01/2019 - 05/2014
2	Overnutrition 01/2016 - 01/2012
2	Neoplasms (Cancer) 06/2015 - 01/2012
2	Diabetic Nephropathies (Diabetic Nephropathy) 05/2015 - 07/2014
1	Weight Loss (Weight Reduction) 01/2020
1	Pulmonary Arterial Hypertension 12/2019
1	Pulmonary Hypertension 12/2019
1	Infections 04/2019
1	Malnutrition (Nutritional Deficiencies) 01/2019
1	Reperfusion Injury 03/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2018
1	Myocardial Infarction 03/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Proteinuria 05/2015
1	Hepatocellular Carcinoma (Hepatoma) 03/2013
1	Chronic Hepatitis C 10/2012
1	Chronic Hepatitis (Chronic Active Hepatitis) 10/2012
1	Hypoadiponectinemia 01/2012
1	Portal Hypertension 01/2012
1	Adenocarcinoma 01/2012

Drug/Important Bio-Agent (IBA)

20	Glucose (Dextrose)FDA LinkGeneric 03/2019 - 03/2007
14	Selenoprotein PIBA 12/2019 - 11/2010
12	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2010
10	Insulin (Novolin)FDA Link 01/2019 - 03/2006
7	Fatty Acids (Saturated Fatty Acids)IBA 06/2015 - 11/2007
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2012 - 07/2008
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2012
5	Chemotactic FactorsIBA 01/2020 - 05/2014
4	LipidsIBA 01/2012 - 11/2007
3	SeleniumIBA 08/2019 - 10/2018
3	Metformin (Glucophage)FDA LinkGeneric 05/2019 - 01/2012
3	Messenger RNA (mRNA)IBA 04/2019 - 03/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018 - 09/2014
3	Short-Acting InsulinIBA 01/2018 - 03/2007
3	Triglycerides (Triacylglycerol)IBA 01/2012 - 01/2007
2	Carrier Proteins (Binding Protein)IBA 08/2019 - 10/2018
2	Phosphotransferases (Kinase)IBA 03/2018 - 03/2013
2	Insulin Aspart (NovoLog)FDA Link 01/2018 - 06/2012
2	A-Form DNA (A-DNA)IBA 01/2018 - 12/2008
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2018 - 03/2015
2	AlbuminsIBA 07/2014 - 10/2012
2	CholesterolIBA 05/2014 - 11/2007
2	AdiponectinIBA 01/2012 - 11/2007
2	DNA (Deoxyribonucleic Acid)IBA 11/2010 - 03/2009
2	Methionine (L-Methionine)FDA Link 07/2008 - 01/2007
2	ProcollagenIBA 07/2008 - 07/2008
2	Choline (Choline Chloride)IBA 07/2008 - 01/2007
2	EnzymesIBA 11/2007 - 03/2006
1	alogliptinIBA 05/2019
1	Antiviral Agents (Antivirals)IBA 04/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Insulin ReceptorIBA 01/2019
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2019
1	Chloroquine (Aralen)FDA LinkGeneric 01/2019
1	Amino Acids FDA Link 01/2019
1	fibroblast growth factor 21IBA 05/2018
1	FollistatinIBA 05/2018
1	Evans Blue (Blue, Evans)FDA Link 03/2018
1	triphenyltetrazoliumIBA 03/2018
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2018
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018
1	Insulin Detemir (Levemir)FDA Link 01/2018
1	Inhibins (Inhibin)IBA 01/2018
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2018
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018
1	Neutralizing AntibodiesIBA 11/2017
1	Vanadium CompoundsIBA 06/2015
1	CreatinineIBA 05/2015
1	Atorvastatin (Lipitor)FDA Link 05/2015
1	Pravastatin (Pravachol)FDA LinkGeneric 05/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2015
1	VildagliptinIBA 03/2015
1	Liraglutide FDA Link 03/2015
1	palmitoleic acidIBA 02/2015
1	Adenosine KinaseIBA 05/2014
1	Protein Kinases (Protein Kinase)IBA 05/2014
1	Ezetimibe (Zetia)FDA Link 05/2014
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2013
1	ATP dependent 26S protease (26S proteasome)IBA 03/2013
1	Bortezomib (Velcade)FDA Link 03/2013
1	Therapeutic UsesIBA 10/2012
1	Branched-Chain Amino AcidsIBA 10/2012
1	somatostatin receptor 2IBA 01/2012

Therapy/Procedure

7	Therapeutics 12/2019 - 03/2006
2	Glycemic Control 03/2015 - 10/2012
1	Diet Therapy (Therapy, Diet) 05/2015